Anales de la RANM

192 A N A L E S R A N M R E V I S T A F U N D A D A E N 1 8 7 9 DUODENOPANCREATECTOMÍA CEFÁLICA EN PACIENTES OCTOGENARIOS CON TUMORES Jiménez Romero C, et al. An RANM. 2023;140(02):185 - 193 DECLARACIÓN DE TRANSPARENCIA Los autores/as de este artículo declaran no tener ningún tipo de conflicto de intereses respecto a lo expuesto en el presente trabajo. BIBLIOGRAFÍA 1. Pirámide de población empadronada en España (1 de enero de 2021). INE. Fuente: Estadística del Padrón Continuo. 2. Las cifras del cáncer en España (2022). Socie- dad Española de Oncología Médica (SEOM). www.seom.org [consultada el 23-02-2022]. 3. Renz BW, Khalil PN, Mikhailov M et al. Pan- creaticoduodenectomy for adenocarcinoma of the pancreatic head is justified in elderly pa- tients: a retrospective Cohort Study. Int J Surg. 2016; 28: 118-125. 4. Ferlay J, Colombet M, Soerjomataram I et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019; 144: 1941-1953. 5. Neoptolemos JP, Palmer DH, Ghanesh P et al. Comparison of adjuvant gemcitabine and ca- pecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ES- PAC-4): a multicentre, open-label, randomized, phase 3 trial. Lancet. 2017; 389: 1011-1024. 6. Bilimoria KY, Bentrem DJ, Ko CY, Stewart AK, Winchester DP, Talamonti MS. National failure to operate on early stage pancreatic cancer. Ann Surg. 2007; 246: 173-180. 7. Hayflick L. The limited in vitro lifetime of hu- man diploid cells strains. Exp Cell Res. 1965; 37: 614-636. 8. Medina-Chávez H, García Rodríguez R. Cáncer: Peculiaridades en el envejecimiento. En: Rodrí- guez García R, Lazcano Botello G. Práctica de la Geriatría. 3ª ed. México: McGraw-Hill; 2011. 9. NCCN. Pancreatic adenocarcinoma. NCCN Clin Pract Guidel Oncol. 2020; 1. 10. Somasundar P, Mourey L, Lozza L, Maggi S, Stepney R. Advances in geriatric oncology: a multidisciplinary perspective. Tumori. 2018; 104: 252-257. 11. Fleisher LA, Fleischmann KE, Auerbach AD et al. ACC/AHA guideline on perioperative cardio- vascular evaluation and management of patients undergoing noncardiac surgery: Executive sum- mary a report of the American College of Car- diology/American Heart Association task force on practice guidelines. Circulation. 2014; 130: 2215-2245. 12. Sadhigi AA. Aging and the immune system: an overview. J Immunol Methods. 2018; 463: 21-26. 13. Matsuda Y. Age-related morphological changes in the pancreas and their association with pancreatic carcinogenesis. Pathol Int. 2019; 69: 450-462. 14. Lafont C, Gerard S, Voisin T, Pahor M, Vellas B, Force T; and members of IAGG/AMP. Reducing “iatrogenic disability” in the hospitalized frail elderly. J Nutr Health Aging. 2011; 15: 645-660. 15. Tsukagoshi M, Harimoto N, Araki K et al. Im- pact of preoperative nutritional support and rehabilitation therapy in patients undergoing pancreaticoduodenectomy. Int J Clin Oncol. 2021; 26: 1698-1706. 16. Mima K, Hayashi H, Nakagawa S et al. Frailty is associated with poor prognosis after resection for pancreatic cancer. Int J Clin Oncol. 2021; 26: 1938-1946. 17. Takeda T, Sasaki T, Suzumori C et al. The impact of cachexia and sarcopenia in elderly pancreatic cancer patients receiving palliative chemothe- rapy. Int J Clin Oncol. 2021; 26: 1293-1303. 18. Lynch SM, Vrieling A, Lubin JH et al. Cigarette smoking ang pancreatic cancer cohort consor- tium. Am J Epidemiol. 2009; 170: 403-413. 19. Ilic M, Ilic I. Epidemiology of pancreatic can- cer. World J Gastroenterol. 2016; 22: 9694-9705. 20. Henrikson NB, Bowles EJ, Blasi PR et al. Scree- ning for pancreatic cancer: updated evidence report and systematic review for the US preven- tive services Task Force. J Am Med Assoc. 2019; 322: 445-454. 21. Graneth P, Hanson R, Titman A et al. PET- PAN: Multicentre prospective diagnosis ac- curacy and health economic analysis study of the impact of combined modality 18fluorine- 2-fluoro-2-deoxy-d-glucose positron emis- sion tomography with computed tomography scanning in the diagnosis and management of pancreatic cancer. Health Tecnol Assess. 2018; 22: 1-114. 22. Baltatzis M, Rodriquenz MG, Siriwardena AK, Cariño NDL. Contemporary management of pancreas cancer in older people. Eur J Surg On- col. 2021; 47(3 Pt A) :560-568. 23. Motoi F, Egawa S, Rikiyama T, Katayose Y, Unno M. Randomized clinical trial of exter- nal stent drainage of the pancreatic duct to reduce postoperative pancreatic fistula after pancreaticojejunostomy. Br J Surg. 2012; 99: 524-531. 24. Pedrazzoli S. Pancreatoduodenectomy (PD) and postoperative pancreatic fistula (POPF): a sys- tematic review and analysis of the POPF-related mortality rate in 60,739 patients retrieved from the English literature published between 1990 and 2015. Medicine. 2017; 96e6858. 25. McMillan MT, Vollmer CM, Asbun HJ et al. The characterization and prediction of ISPF grade C fistulas following pancreatoduodenectomy. J Gastrointest Surg. 2016; 20: 262-276. 26. Justo Alonso I, Alonso Murillo L, Marcacuzco Quinto A et al. Duodenopancreatectomía cefá- lica en pacientes octogenarios con tumores de páncreas. Cir Esp. 2023 (en prensa). 27. Callery MP, Pratt WB, Kent TS, Chaikof EL, Vollmer CM Jr. A prospectively validated clini- cal risk score accurately predicts pancreatic fis- tula after pancreaticoduodenectomy. J Am Coll Surg. 2013; 216: 1-14. 28. Bramhall SR, Allum WH, Jones AG, Alwood A, Cummins C, Neoptolemos JP. Treatment and survival in 13,560 patients with pancreatic can- cer, and incidence of the disease, in the West Midlands: an epidemiological study. Br J Surg. 1995; 82: 111-115.